US Edition
AxoGen: Q4 Earnings Snapshot
- On Tuesday, AxoGen Inc. in Alachua, Fla., reported a fourth-quarter loss of $13200K, reversing a profit from the same period last year.
- For the year, AxoGen said its loss widened to $15.7 million on revenue of $225.2 million.
- Adjusting the opening to 'AxoGen said,' quarterly revenue was $59.9 million, and adjusted earnings per share were reported positive.
- Market reaction showed AxoGen shares year-to-date performance at 8% and shares 12-month performance at 97%.
- Management set guidance to full-year revenue of $265.7 million, and the report was distributed by the Associated Press using Zacks data via Automated Insights.
27 Articles
27 Articles
AxoGen (NASDAQ:AXGN) Issues Earnings Results
AxoGen (NASDAQ:AXGN - Get Free Report) posted its quarterly earnings data on Tuesday. The medical equipment provider reported ($0.28) EPS for the quarter, missing analysts' consensus estimates of $0.08 by ($0.36). The business had revenue of $59.90 million during the quarter, compared to analysts' expectations of $59.90 million. AxoGen had a negative net margin of 0.98% and a negative return on equity of 1.90%.
AxoGen: Q4 Earnings Snapshot
ALACHUA, Fla. (AP) — ALACHUA, Fla. (AP) — AxoGen Inc. (AXGN) on Tuesday reported a fourth-quarter loss of $13.2 million, after reporting a profit in the same period a year earlier. The Alachua, Florida-based company said it had a loss of 28 cents per share. Earnings, adjusted for stock option expense, were 7 cents per share. The regenerative medicine company posted revenue of $59.9 million in the period. For the year, the company reported that i…
Coverage Details
Bias Distribution
- 60% of the sources are Center
Factuality
To view factuality data please Upgrade to Premium